DE3434082C2 - - Google Patents

Info

Publication number
DE3434082C2
DE3434082C2 DE19843434082 DE3434082A DE3434082C2 DE 3434082 C2 DE3434082 C2 DE 3434082C2 DE 19843434082 DE19843434082 DE 19843434082 DE 3434082 A DE3434082 A DE 3434082A DE 3434082 C2 DE3434082 C2 DE 3434082C2
Authority
DE
Germany
Prior art keywords
crosslinking agent
hyaluronic acid
water
treatment
crosslinking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE19843434082
Other languages
German (de)
English (en)
Other versions
DE3434082A1 (de
Inventor
Endre A. Riverdale N.Y. Us Balazs
Adolf Brooklyn N.Y. Us Leshchiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Biosurgery Inc
Original Assignee
Biomatrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomatrix Inc filed Critical Biomatrix Inc
Publication of DE3434082A1 publication Critical patent/DE3434082A1/de
Application granted granted Critical
Publication of DE3434082C2 publication Critical patent/DE3434082C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE19843434082 1983-12-15 1984-09-17 Wasserunloesliche zubereitung von hyaluronsaeure Granted DE3434082A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56181883A 1983-12-15 1983-12-15

Publications (2)

Publication Number Publication Date
DE3434082A1 DE3434082A1 (de) 1985-07-11
DE3434082C2 true DE3434082C2 (enExample) 1991-02-21

Family

ID=24243605

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19843434082 Granted DE3434082A1 (de) 1983-12-15 1984-09-17 Wasserunloesliche zubereitung von hyaluronsaeure

Country Status (2)

Country Link
JP (1) JPS60130601A (enExample)
DE (1) DE3434082A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61164558A (ja) * 1985-01-17 1986-07-25 生化学工業株式会社 医療用成形物の成形材料
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
SE456346B (sv) * 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
US5202431A (en) * 1985-07-08 1993-04-13 Fidia, S.P.A. Partial esters of hyaluronic acid
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
EP0224987B1 (en) * 1985-11-29 1992-04-15 Biomatrix, Inc. Drug delivery systems based on hyaluronan, derivatives thereof and their salts and method of producing same
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5658592A (en) * 1994-05-13 1997-08-19 Kuraray Co., Ltd. Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane
AU2003230948A1 (en) * 2002-04-17 2003-11-03 Genzyme Corporation Cross-linked hyaluronate compounds
ES2406555T3 (es) 2003-10-29 2013-06-07 Teijin Limited Compuesto de ácido hialurónico, hidrogel del mismo y material para tratar articulaciones
AU2006276435B2 (en) 2005-08-04 2011-10-13 Teijin Limited Cellulose derivative
CN101821294B (zh) 2007-09-28 2012-10-31 株式会社资生堂 溶胀性交联透明质酸粉末及其制造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152170A (en) * 1975-06-18 1979-05-01 Sumitomo Chemical Company, Ltd. Cross-linked pullulan
GB1515963A (en) * 1975-07-15 1978-06-28 Massachusetts Inst Technology Crosslinked collagen-mucopolysaccharide composite materials

Also Published As

Publication number Publication date
DE3434082A1 (de) 1985-07-11
JPS60130601A (ja) 1985-07-12

Similar Documents

Publication Publication Date Title
DE3434104C2 (enExample)
DE3434123C2 (enExample)
DE2812174C2 (de) Die Blutgerinnung nicht fördernde, biologisch verträgliche Gegenstände
DE2735179C3 (de) Hämoperfusionsadsorbens aus einem absorbierend wirkenden Material
DE3785147T2 (de) Membran aus regenerierter Zellulose und Verfahren zu ihrer Herstellung.
DE1720955C3 (de) Verfahren zur Herstellung eine polymeren Formgegenstands mit gegenüber Proteinen reaktiongsfähigen Gruppen auf seiner Oberfläche
DE3434042A1 (de) Hyaluronatmodifizierter polymerer artikel
DE69330386T2 (de) Verfahren zur verminderung von mikroorganismenhaftung
DE2617404A1 (de) Klebstoff zum kleben der weichgewebe des organismus
DE69628162T2 (de) Polymermaterial, medizinisches material und flüssige polymerzusammensetzung
DE2631908A1 (de) Vernetztes polymeres
DE69218477T2 (de) Medizinisches Material, Verfahren zu seiner Herstellung und medizinisches Gerät
DE3434082A1 (de) Wasserunloesliche zubereitung von hyaluronsaeure
DE2528068A1 (de) Wasserunloesliche hydrophile copolymere
EP0374659A2 (de) Optisch klare Silikonmassen
DE2309894A1 (de) Verfahren zur herstellung von loeslichen hydrophilen polymeren
DE2833072A1 (de) Verfahren zur herstellung von biologisch vertraeglichen materialien und die nach diesem verfahren erhaltenen gegenstaende
DE2711383C3 (de) Polysiloxangele und deren Verwendung
DE3784518T3 (de) Medizinisches material und verfahren zur herstellung.
DE69807800T2 (de) Nicht zytotoxische medizinische Artikel aus Polyurethan
DE19981169B4 (de) Kovalent an Gallensäuren oder Sterine gebundenes Heparin, dessen Verwendung und diese enthaltende pharmazeutische Zusammensetzung
DE69715667T2 (de) Verfahren zur herstellung einer multipartikulären pharmazeutischen form mitgesteuerter etappenweiser freisetzung
DE2647389A1 (de) Verfahren zur herstellung eines antikoagulans-organosilikonpolymeren
EP1282695B1 (de) Blutkompatible polymeroberflächen
EP1099468A2 (de) Mikroporöse hydrophile Membran

Legal Events

Date Code Title Description
AG Has addition no.

Ref country code: DE

Ref document number: 3434104

Format of ref document f/p: P

8110 Request for examination paragraph 44
AG Has addition no.

Ref country code: DE

Ref document number: 3434104

Format of ref document f/p: P

D2 Grant after examination
AG Has addition no.

Ref country code: DE

Ref document number: 3434104

Format of ref document f/p: P

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GENZYME BIOSURGERY CORPORATION, CAMBRIDGE, MASS.,